161 related articles for article (PubMed ID: 6118718)
1. Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy.
Campbell FC; Blamey RW; Elston CW; Morris AH; Nicholson RI; Griffiths K; Haybittle JL
Lancet; 1981 Dec; 2(8259):1317-9. PubMed ID: 6118718
[TBL] [Abstract][Full Text] [Related]
2. The prediction of hormonal dependency of mammary cancer.
Block GE; Jensen EV; Polley TZ
Ann Surg; 1975 Sep; 182(3):342-52. PubMed ID: 169754
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptors and breast cancer.
Nicholson RI; Griffiths K; Blamey RW; Bishop HM; Haybittle JL
Environ Health Perspect; 1981 Apr; 38():143-6. PubMed ID: 7238443
[TBL] [Abstract][Full Text] [Related]
4. Clinical data and estradiol receptor evaluation in breast cancer biopsies.
Di Fronzo G; Bertuzzi A; Saccozzi R
Tumori; 1979 Apr; 65(2):221-8. PubMed ID: 462574
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values.
Rose C; Thorpe SM; Andersen KW; Pedersen BV; Mouridsen HT; Blichert-Toft M; Rasmussen BB
Lancet; 1985 Jan; 1(8419):16-9. PubMed ID: 2856949
[TBL] [Abstract][Full Text] [Related]
6. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptors and breast cancer: prognostic and therapeutic implications.
Gapinski PV; Donegan WL
Surgery; 1980 Sep; 88(3):386-93. PubMed ID: 7414516
[TBL] [Abstract][Full Text] [Related]
8. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.
Kuukasjärvi T; Kononen J; Helin H; Holli K; Isola J
J Clin Oncol; 1996 Sep; 14(9):2584-9. PubMed ID: 8823339
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability.
Leake RE; Laing L; Calman KC; Macbeth FR; Crawford D; Smith DC
Br J Cancer; 1981 Jan; 43(1):59-66. PubMed ID: 7459239
[TBL] [Abstract][Full Text] [Related]
10. Combined modality therapy for first recurrence of breast cancer. A Southwest Oncology Group study.
Hoogstraten B; Gad-el-Mawla N; Maloney TR; Fletcher WS; Vaughn CB; Tranum BL; Athens JW; Costanzi JJ; Foulkes M
Cancer; 1984 Nov; 54(10):2248-56. PubMed ID: 6488144
[TBL] [Abstract][Full Text] [Related]
11. Progesterone and oestrogen receptors in human breast cancer.
Holdaway IM; Mountjoy KG
Aust N Z J Med; 1978 Dec; 8(6):630-8. PubMed ID: 285684
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen and oophorectomy in the treatment of recurrent breast cancer: a Southwest Oncology Group Study.
Hoogstraten B; Fletcher WS; Gad-el-Mawla N; Maloney T; Altman SJ; Vaughn CB; Foulkes MA
Cancer Res; 1982 Nov; 42(11):4788-91. PubMed ID: 7127314
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor in breast cancer of the Japanese.
Nomura Y
Gan; 1976 Oct; 67(5):703-11. PubMed ID: 190078
[TBL] [Abstract][Full Text] [Related]
14. Experience with a simple method for estrogen receptor assay in breast cancer.
Liskowski L; Rose DP
Clin Chim Acta; 1976 Mar; 67(2):175-82. PubMed ID: 2401
[TBL] [Abstract][Full Text] [Related]
15. Oestrogen-receptor status and sites of metastasis in breast cancer.
Campbell FC; Blamey RW; Elston CW; Nicholson RI; Griffiths K; Haybittle JL
Br J Cancer; 1981 Sep; 44(3):456-9. PubMed ID: 7284240
[TBL] [Abstract][Full Text] [Related]
16. Progesterone receptor status of breast cancer metastases.
Branković-Magić M; Janković R; Nesković-Konstantinović Z; Nikolić-Vukosavljević D
J Cancer Res Clin Oncol; 2002 Jan; 128(1):55-60. PubMed ID: 11862473
[TBL] [Abstract][Full Text] [Related]
17. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.
Henry JA; Nicholson S; Hennessy C; Lennard TW; May FE; Westley BR
Br J Cancer; 1990 Jan; 61(1):32-8. PubMed ID: 2153395
[TBL] [Abstract][Full Text] [Related]
18. Oophorectomy/adrenalectomy.
Schweitzer RJ
Cancer; 1980 Aug; 46(4 Suppl):1061-5. PubMed ID: 7397658
[TBL] [Abstract][Full Text] [Related]
19. Symposium on the management of early breast cancer (stages I and II). Part II: Clinical experience with treatment methods. 5. Adjuvant endocrine therapy.
Palshof T
Can J Surg; 1981 Jul; 24(4):379-84. PubMed ID: 7023634
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh.
Lancet; 1987 Jul; 2(8552):171-5. PubMed ID: 2885637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
